Published in BMC Microbiol on March 12, 2010
Subversion of host recognition and defense systems by Francisella spp. Microbiol Mol Biol Rev (2012) 1.40
Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One (2011) 1.02
Bacterial plasminogen receptors: mediators of a multifaceted relationship. J Biomed Biotechnol (2012) 0.99
Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J Bacteriol (1973) 16.62
An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med (2001) 4.60
A surface protease and the invasive character of plague. Science (1992) 4.44
An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun (2003) 4.37
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82
Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell (1997) 3.25
The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem (2000) 3.24
A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med (1998) 3.03
Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science (2004) 2.91
The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth. BMC Microbiol (2007) 2.81
A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun (1988) 2.34
Bacterial plasminogen activators and receptors. FEMS Microbiol Rev (2001) 2.19
The ecology of tularemia. Adv Vet Sci Comp Med (1974) 2.05
Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun (2001) 2.02
Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem (2003) 1.99
Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun (2005) 1.95
Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol (2007) 1.74
Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost (2007) 1.66
LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun (2006) 1.61
Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol (2005) 1.59
Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis (2007) 1.58
The interaction between pathogens and the host coagulation system. Physiology (Bethesda) (2006) 1.58
The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis (2002) 1.58
Airborne transmission of tularemia in farmers. Scand J Infect Dis (1985) 1.52
Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur J Immunol (2003) 1.45
Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol (2006) 1.32
Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii. Infect Immun (2005) 1.27
Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect Immun (2008) 1.25
Identification of a Treponema denticola OppA homologue that binds host proteins present in the subgingival environment. Infect Immun (2000) 1.23
Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int J Med Microbiol (2004) 1.18
alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis. Biochim Biophys Acta (2008) 1.17
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Water- and airborne Francisella tularensis biovar palaearctica isolated from human blood. Infection (1992) 1.12
An outbreak of airborne tularaemia in France, August 2004. Euro Surveill (2006) 1.06
Frequent isolation of Francisella tularensis from Dermacentor reticulatus ticks in an enzootic focus of tularaemia. Med Vet Entomol (1996) 1.06
A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis. J Immunol (2009) 1.03
Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J Leukoc Biol (2008) 1.03
The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis (2003) 1.03
Tularemia transmitted by insect bites--Wyoming, 2001-2003. MMWR Morb Mortal Wkly Rep (2005) 1.01
Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis (1999) 0.99
The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge. Eur J Clin Microbiol Infect Dis (2007) 0.99
Using every trick in the book: the Pla surface protease of Yersinia pestis. Adv Exp Med Biol (2007) 0.98
Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum. J Immunol (2008) 0.97
Complement regulator-acquiring surface proteins of Borrelia burgdorferi: a new protein family involved in complement resistance. Wien Klin Wochenschr (2002) 0.92
A family outbreak of tularemia. Eur J Epidemiol (1985) 0.91
The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils. Microbes Infect (2009) 0.90
The cell envelope-bound metalloprotease (camelysin) from Bacillus cereus is a possible pathogenic factor. Biochim Biophys Acta (2001) 0.86
Characterization of plasmin(ogen) binding to Streptococcus pneumoniae. Indian J Med Res (2004) 0.84
Tularemia in a mule deer. J Wildl Dis (1976) 0.76
Landmark article April 25, 1925: Tularemia. By Edward Francis. JAMA (1983) 0.76
[Mosquitoes in the northern part of Szczecin region and their role in epidemiology of tularemia]. Biul Panstw Inst Med Morsk Trop J W Gdansku (1955) 0.76
Interactions between human plasma proteins and cell wall components of Staphylococcus aureus. Dan Med Bull (1987) 0.76
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Synchrony, waves, and spatial hierarchies in the spread of influenza. Science (2006) 10.43
Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med (2011) 10.29
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99
Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med (2005) 8.46
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 5.91
Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol (2004) 5.26
Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis (2005) 4.75
Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine (2006) 4.28
Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol (2007) 4.06
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis (2012) 3.31
Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg (2006) 3.20
Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ Health Perspect (2010) 3.09
RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature (2005) 2.93
Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis (2004) 2.80
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol (2007) 2.59
Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog (2007) 2.52
Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med (2011) 2.41
Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences. J Infect Dis (2011) 2.33
Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog (2008) 2.09
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol (2013) 2.06
Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis (2011) 1.87
Early cement damage around a femoral stem is concentrated at the cement/bone interface. J Biomech (2003) 1.85
Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One (2013) 1.84
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis (2011) 1.83
Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics (2007) 1.79
Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations. J Infect Dis (2010) 1.78
Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog (2011) 1.68
Comparison of PCR and culture for screening of vancomycin-resistant Enterococci: highly disparate results for vanA and vanB. J Clin Microbiol (2009) 1.62
A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? J Gen Virol (2002) 1.60
The dilemma of influenza vaccine recommendations when applied to the tropics: the Brazilian case examined under alternative scenarios. PLoS One (2009) 1.57
Clostridium difficile: a formidable foe. CMAJ (2004) 1.54
Geographical distribution and risk factors associated with enteric diseases in Vietnam. Am J Trop Med Hyg (2007) 1.53
Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J Leukoc Biol (2006) 1.52
Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer. J Biol Chem (2007) 1.49
Air travel and the spread of influenza: important caveats. PLoS Med (2006) 1.49
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis (2012) 1.47
Crystal structure of thy1, a thymidylate synthase complementing protein from Thermotoga maritima at 2.25 A resolution. Proteins (2002) 1.45
Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res (2014) 1.40
Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest (2004) 1.39
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis (2012) 1.39
Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNgamma-mediated host cell tryptophan starvation. Mol Microbiol (2006) 1.38
Spatial and temporal characteristics of the 2009 A/H1N1 influenza pandemic in Peru. PLoS One (2011) 1.35
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J (2007) 1.35
Experimental micromechanics of the cement-bone interface. J Orthop Res (2008) 1.34
The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol (2002) 1.32
Rhabdovirus assembly and budding. Virus Res (2004) 1.32
Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine (2006) 1.31
Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure. Circulation (2005) 1.27
Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J Virol (2002) 1.26
Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect Immun (2008) 1.26
Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch Med Res (2012) 1.25
Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine (2009) 1.24
Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS One (2009) 1.24
Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J Virol (2007) 1.24
1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis (2006) 1.23
Reversible self-assembly of patchy particles into monodisperse icosahedral clusters. J Chem Phys (2007) 1.22
The influence of climatic conditions on the transmission dynamics of the 2009 A/H1N1 influenza pandemic in Chile. BMC Infect Dis (2012) 1.22
Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis (2007) 1.22
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology (2009) 1.21
Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia. PLoS One (2012) 1.20
Creep dominates tensile fatigue damage of the cement-bone interface. J Orthop Res (2004) 1.17
Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience. PLoS One (2012) 1.17
Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med (2013) 1.14
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine (2009) 1.14
Macrophage replication screen identifies a novel Francisella hydroperoxide resistance protein involved in virulence. PLoS One (2011) 1.14
Temporal trends and climatic factors associated with bacterial enteric diseases in Vietnam, 1991-2001. Environ Health Perspect (2008) 1.13
The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol (2003) 1.13
Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine (2011) 1.13
Estimating deaths due to influenza and respiratory syncytial virus. JAMA (2003) 1.11
The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol Lett (2007) 1.11
Functional analysis of late-budding domain activity associated with the PSAP motif within the vesicular stomatitis virus M protein. J Virol (2004) 1.10
Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity. J Infect Dis (2011) 1.10
Effect of an educational intervention on optimizing antibiotic prescribing in long-term care facilities. J Am Geriatr Soc (2007) 1.09
The need for interdisciplinary studies of historic pandemics. Vaccine (2011) 1.09
Functional interface micromechanics of 11 en-bloc retrieved cemented femoral hip replacements. Acta Orthop (2010) 1.08
Shear fatigue micromechanics of the cement-bone interface: An in vitro study using digital image correlation techniques. J Orthop Res (2009) 1.07
The effect of low-viscosity cement on mantle morphology and femoral stem micromotion: a cadaver model with simulated blood flow. Acta Orthop (2006) 1.07
A new approach to quantify trabecular resorption adjacent to cemented knee arthroplasty. J Biomech (2012) 1.07
The Bla2 beta-lactamase from the live-vaccine strain of Francisella tularensis encodes a functional protein that is only active against penicillin-class beta-lactam antibiotics. Arch Microbiol (2006) 1.04
Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection. Clin Infect Dis (2012) 1.04
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension. Circulation (2008) 1.04
Comparative dynamics, morbidity and mortality burden of pediatric viral respiratory infections in an equatorial city. Pediatr Infect Dis J (2012) 1.02
Evaluation of Southern Hemisphere influenza vaccine recommendations. Vaccine (2010) 1.02
The 1918-19 influenza pandemic in Boyacá, Colombia. Emerg Infect Dis (2012) 1.02
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? Vaccine (2005) 1.01
Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc (2013) 1.00
Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Eur J Immunol (2007) 1.00
Crystal structure of an iron-containing 1,3-propanediol dehydrogenase (TM0920) from Thermotoga maritima at 1.3 A resolution. Proteins (2004) 1.00
Cement-implant interface gaps explain the poor results of CMW3 for femoral stem fixation: A cadaver study of migration, fatigue and mantle morphology. Acta Orthop (2005) 1.00
Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico. PLoS One (2012) 0.98